|Day Low/High||0.49 / 0.56|
|52 Wk Low/High||0.29 / 1.32|
Strong Consumer Feedback from Pilot Serenz Sales in the UK
- Pilot Program to Include 25 Community Pharmacies -
-Agreement represents continued expansion of CoSense outside the US-
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AKAM, BTN, JNP, NOA, SUNS Downgrades: EDUC, ENSG, FOXA, GZT, LVS, TUBE, WETF Initiations: CAPN Read on to get TheStreet Quant Ratings' detailed report:
-Early 2016 Marked by Commencement of Serenz® Sales to European Pharmacies and New Global Distribution Agreements for CoSense® -
Appointment Adds Significant Leadership Experience in Medical Devices and Diagnostics
Capnia (CAPN) stock is rising in early-morning trading on Wednesday after the company announced a five-year distribution agreement in China.
Five-year agreement represents significant expansion of CoSense outside the US
Company on track to initiate pilot sales through European Union pharmacies in second quarter 2016
Capnia and Bemes Enter Collaboration Targeting Hospitals and Physicians
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.